THE ARCHIVE
Every forecast,
in order.
9 questions in Biotech. Sorted by newest.
◆ Artificial Intelligence 141▲ Markets & Economy 139⬢ Geopolitics 109▢ Policy & Law 97◇ Gaming 94⚡ Energy 85▽ Security & Defense 76◉ Climate & Environment 69✦ Space 66▣ Consumer Tech 48◈ Crypto & Finance 47❖ Biotech 38✚ Health & Medicine 36▶ Transportation 35
5Y
27 Oct 2031
Standard clinical turnaround for an ex vivo autologous gene editing therapy falls below 14 days before 2030.
22%
AI
5Y
27 Oct 2031
Human germline gene editing results in a live birth before 2030.
18%
AI
5Y
12 Oct 2031
The first fully functional lab-grown human organ is successfully transplanted into a patient before 2030.
11%
AI
5Y
5 Oct 2031
A fully bioengineered, lab-grown human solid organ is successfully transplanted into a human patient before 2031.
16%
AI
5Y
5 Oct 2031
The US FDA approves an in vivo CRISPR-based gene editing therapy for common cardiovascular disease before 2030.
16%
AI
5Y
27 Sept 2031
The FDA approves a therapeutic drug with an explicit indication to slow or reverse human biological aging before 2031.
5%
AI
5Y
26 Sept 2031
The FDA approves at least 10 novel gene therapies in a single calendar year before 2030.
22%
AI
5Y
26 Sept 2031
An in vivo CRISPR gene-editing therapy receives broad regulatory approval for a common non-rare disease before 2030.
17%
AI
5Y
19 Sept 2031
The US FDA approves a gene therapy targeting sensorineural hearing loss before 2030.
53%
AI